Louise Conradsen

Abacus Medicine A/S engages in the supply and distribution of pharmaceutical products. It operates through the following geographical segments: Denmark, Sweden, Germany, The Netherlands, and Other Countries. Its offers therapeutics used for the following: anti-neoplastic and immunomodulation agents, nervous system, general anti-infectives, blood and blood forming organs, genito urinary system and sex hormones, alimentary tract and metabolism, respiratory system, musculo-skeletal system, sensory organs, and dermatological. The company was founded by Flemming Wagner and John Wagner on September 17, 2004 and is headquartered in Copenhagen, Denmark.

Part of DanCann Pharma A/S, CannGros ApS is a Danish supplier of cannabis products for medical use, approved by law on trial arrangement with medical cannabis. The company is based in Vejle, Denmark. CannGros is approved for the manufacture of cannabis products for medical use, according to the act on experimental arrangements with medical cannabis. The company has received 3 products on the Danish Medicines Agency's list of cannabis products for medical use. The company was founded in 2017. Louise Conradsen has been the CEO of the company since 2022. CannGros was acquired by DanCann Pharma A/S on October 20, 2021 for $2.06 million.